MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma

Hongsheng Yue1, Jie Zhu1, Shugang Xie2

  • 1Department of Neurosurgery, Ji'nan Central Hospital Affiliated to Shandong University, Ji'nan 250013, PR China.

Abstract

Insights

Mediator of DNA damage checkpoint protein 1 antisense RNA (MDC1-AS) acts as a tumor suppressor in glioma. Its downregulation correlates with glioma progression, suggesting MDC1-AS as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long noncoding RNAs (lncRNAs) are increasingly recognized as key regulators in cancer development and progression.
  • Mediator of DNA damage checkpoint protein 1 antisense RNA (MDC1-AS), a lncRNA with an uncharacterized function, is the antisense transcript of the tumor suppressor gene MDC1.

Purpose of the Study:

  • To investigate the expression patterns and functional significance of lncRNA MDC1-AS in glioma.
  • To elucidate the role of MDC1-AS in glioma cell proliferation and cell cycle regulation.

Main Methods:

  • Real-time PCR was employed to determine expression levels of MDC1-AS and MDC1 in glioma tissues and cell lines.
  • Gain- and loss-of-function studies were conducted to assess the impact of MDC1-AS on glioma cell behavior.

Main Results:

  • lncRNA MDC1-AS and MDC1 expression were significantly reduced in glioma tissues and cell lines compared to normal controls.
  • Overexpression of MDC1-AS inhibited glioma cell proliferation and cell cycle progression.
  • MDC1-AS expression positively correlated with MDC1 expression, and its inhibitory effect was dependent on MDC1 levels.

Conclusions:

  • MDC1-AS functions as a novel tumor suppressor in glioma by upregulating its antisense tumor-suppressing gene, MDC1.
  • MDC1-AS presents a promising potential biomarker and therapeutic target for glioma treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K